Patents Assigned to Amyris, Inc.
  • Patent number: 12188044
    Abstract: The present invention provides high efficiency targeted and marker-less single or simultaneous multiple integrations using nucleases and a stable plasmid in Kluyveromyces host cells.
    Type: Grant
    Filed: May 18, 2023
    Date of Patent: January 7, 2025
    Assignee: Amyris, Inc.
    Inventor: Jessica Walter
  • Patent number: 12168769
    Abstract: The present invention provides high efficiency targeted and marker-less single, double, triple, quadruple, and quintuple integrations by using CRISPR in host cells, including Pichia.
    Type: Grant
    Filed: June 15, 2022
    Date of Patent: December 17, 2024
    Assignee: Amyris, Inc.
    Inventor: Hanxiao Jiang
  • Patent number: 12098407
    Abstract: Provided herein are compositions and methods for uncoupling the yield and productivity of an isoprenoid compound produced in a host cell. In some embodiments, the yield and productivity are uncoupled by genetically modifying the host cell to reduce flux through the citric acid cycle (TCA). In other embodiments, the yield and productivity are uncoupled by reducing the levels of ATP in the host cell.
    Type: Grant
    Filed: June 5, 2020
    Date of Patent: September 24, 2024
    Assignee: Amyris Inc.
    Inventors: Penelope R. Chua, Joshua Adam Lerman, Thomas Jon Scherbart, Chandresh Thakker, Annie Ening Tsong, Hanxiao Jiang
  • Patent number: 12031169
    Abstract: Provided herein are compounds, compositions, and methods for recovery of one or more water-immiscible compounds from microbial biomass.
    Type: Grant
    Filed: April 25, 2022
    Date of Patent: July 9, 2024
    Assignee: Amyris, Inc.
    Inventors: Ronald Ray Henry, Joshua Steven Leng
  • Publication number: 20240099950
    Abstract: The disclosure provides cosmetic compositions including cannabigerol (CBG), as well as methods of using the same for reducing skin redness, improving skin barrier functionality, brightening the skin of a subject, and enhancing the outward appearance of the skin of a subject (e.g., a male or female human subject).
    Type: Application
    Filed: January 11, 2022
    Publication date: March 28, 2024
    Applicant: Amyris, Inc.
    Inventors: Diva CHAN, Ro OTERI, Ashlee NUNES
  • Patent number: 11884928
    Abstract: The invention provides methods for genetically engineering Kluyveromyces. The methods can be used to genetically engineer Kluyveromyces to produce and secrete full-length antibodies or antibody fragments. The invention also provides methods for production and secretion of antibodies.
    Type: Grant
    Filed: September 12, 2018
    Date of Patent: January 30, 2024
    Assignee: Amyris, Inc.
    Inventor: Yoseph Tsegaye
  • Patent number: 11802100
    Abstract: Provided herein are olefinic feedstocks derived from conjugated hydrocarbon terpenes (e.g., C10-C50 terpenes), methods for making the same, and methods for their use.
    Type: Grant
    Filed: November 3, 2021
    Date of Patent: October 31, 2023
    Assignee: Amyris, Inc.
    Inventors: Nicholas Ohler, Karl Fisher, Jin Ki Hong
  • Patent number: 11685934
    Abstract: The present invention provides high efficiency targeted and marker-less single or simultaneous multiple integrations using nucleases and a stable plasmid in Kluyveromyces host cells.
    Type: Grant
    Filed: September 12, 2018
    Date of Patent: June 27, 2023
    Assignee: Amyris, Inc.
    Inventor: Jessica Walter
  • Patent number: 11390874
    Abstract: The present invention provides high efficiency targeted and marker-less single, double, triple, quadruple, and quintuple integrations by using CRISPR in host cells, including Pichia.
    Type: Grant
    Filed: September 12, 2018
    Date of Patent: July 19, 2022
    Assignee: Amyris, Inc.
    Inventor: Hanxiao Jiang
  • Patent number: 11219586
    Abstract: Provided herein are compositions for delivering one or more cannabinoids to the skin of a subject and methods of using the compositions to deliver the one or more cannabinoids to the skin of a subject. The compositions contain a carrier that facilitates the delivery and permeation of cannabinoids to and through the skin. The carriers of the compositions contain squalane or mixtures of squalane and hemisqualane. The compositions described herein may serve as the base for the preparation of various cosmetics or various pharmaceuticals. The cosmetics or pharmaceuticals may be used to reduce inflammation, control pain, or prevent aging of the skin of a subject.
    Type: Grant
    Filed: July 14, 2021
    Date of Patent: January 11, 2022
    Assignee: Amyris, Inc.
    Inventors: Diva Chan, Ro Oteri, Ashlee Nunes
  • Patent number: 11213467
    Abstract: Provided herein are compositions for delivering one or more cannabinoids to the skin of a subject and methods of using the compositions to deliver the one or more cannabinoids to the skin of a subject. The compositions contain a carrier that facilitates the delivery and permeation of cannabinoids to and through the skin. The carriers of the compositions contain squalane or mixtures of squalane and hemisqualane. The compositions described herein may serve as the base for the preparation of various cosmetics or various pharmaceuticals. The cosmetics or pharmaceuticals may be used to reduce inflammation, control pain, or prevent aging of the skin of a subject.
    Type: Grant
    Filed: March 19, 2021
    Date of Patent: January 4, 2022
    Assignee: Amyris, Inc.
    Inventors: Diva Chan, Ro Oteri, Ashlee Nunes
  • Patent number: 11103808
    Abstract: The present invention is a process for recovering an isoprenoid compound produced by fermentation from a fermentation medium comprising: (a) demulsifying the fermentation medium or a fraction thereof in presence of a salt and a surfactant, thereby generating a stream having an organic phase containing the isoprenoid compound and a phase heavier than the organic phase, and (b) separating the stream obtained in step (a) into the organic phase containing the isoprenoid compound, the phase heavier than the organic phase, and optionally a solid phase containing host cell debris and cells.
    Type: Grant
    Filed: August 1, 2018
    Date of Patent: August 31, 2021
    Assignee: Amyris, Inc.
    Inventors: Maha Bahi, Anthony Hutin, Fernando Leal-Calderon
  • Publication number: 20200354746
    Abstract: Provided herein are methods of integrating one or more exogenous nucleic acids into one or more selected target sites of a host cell genome. in certain embodiments, the methods comprise contacting the host cell genome with one or more integration polynucleotides comprising an exogenous nucleic acid to be integrated into a genomic target site, a nuclease capable of causing a break at the genomic target site, and a linear nucleic acid capable of homologous recombination with itself or with one or more additional linear nucleic acids contacted with the population of cells, whereupon said homologous recombination results in formation of a circular extrachromosomal nucleic acid comprising a coding sequence for a selectable marker. in some embodiments, the methods further comprise selecting a host cell that expresses the selectable marker.
    Type: Application
    Filed: March 11, 2020
    Publication date: November 12, 2020
    Applicant: Amyris, Inc.
    Inventors: Andrew HORWITZ, Kristy Michelle HAWKINS, Max SCHUBERT, Wayne SZETO
  • Patent number: 10563229
    Abstract: The present disclosure relates to the use of a switch for the production of heterologous non-catabolic compounds in microbial host cells. In one aspect, provided herein are genetically modified microorganisms that produce non-catabolic compounds more stably when serially cultured under aerobic conditions followed by microaerobic conditions, and methods of producing non-catabolic compounds by culturing the genetically modified microbes under such culture conditions. In another aspect, provided herein are genetically modified microorganisms that produce non-catabolic compounds more stably when serially cultured in the presence of maltose followed by the reduction or absence of maltose, and methods of producing non-catabolic compounds by culturing the genetically modified microbes under such culture conditions.
    Type: Grant
    Filed: August 7, 2013
    Date of Patent: February 18, 2020
    Assignees: Amyris, Inc., Total Marketing Services
    Inventors: Penelope R. Chua, Adam Meadows
  • Patent number: 10519475
    Abstract: Provided herein are genetically modified yeast cells capable of producing one or more human milk oligosaccharides. The yeast cells include one or more heterologous nucleic acids that encode enzymes of a human milk oligosaccharide biosynthetic pathway. The yeast cells do not include a heterologous nucleic acid encoding a fucokinase. Also provided are fermentation compositions including the disclosed genetically modified yeast cells, and related methods of producing and recovering human milk oligosaccharides generated by the yeast cells.
    Type: Grant
    Filed: November 21, 2018
    Date of Patent: December 31, 2019
    Assignee: Amyris, Inc.
    Inventors: Jessica Walter, Joshua A. Lerman, Michael Leavell, Benjamin Yap
  • Publication number: 20190017074
    Abstract: Provided herein are methods of integrating one or more exogenous nucleic acids into one or more selected target sites of a host cell genome. In certain embodiments, the methods comprise contacting the host cell genome with one or more integration polynucleotides comprising an exogenous nucleic acid to be integrated into a genomic target site, a nuclease capable of causing a break at the genomic target site, and a linear nucleic acid capable of homologous recombination with itself or with one or more additional linear nucleic acids contacted with the population of cells, whereupon said homologous recombination results in formation of a circular extrachromosomal nucleic acid comprising a coding sequence for a selectable marker. In some embodiments, the methods further comprise selecting a host cell that expresses the selectable marker.
    Type: Application
    Filed: July 24, 2018
    Publication date: January 17, 2019
    Applicant: Amyris, Inc.
    Inventors: Andrew Horwitz, Kristy Michelle Hawkins, Max Schubert, Wayne Szeto
  • Patent number: 10125376
    Abstract: Provided herein is a gaseous isoprene composition comprising isoprene, carbon dioxide and water, wherein the isoprene is in an amount between about 0.1% and about 15% by volume; wherein the carbon dioxide is in an amount between about 0.04% and about 35% by volume; wherein the water is in an amount greater than about 70% of its saturation amount. Also provided herein is a liquid isoprene composition comprising isoprene in an amount of at least 65% by weight and carbon dioxide in an amount between about 0.01% and about 1% by weight.
    Type: Grant
    Filed: December 21, 2017
    Date of Patent: November 13, 2018
    Assignee: Amyris, Inc.
    Inventor: Derek McPhee
  • Patent number: 10106822
    Abstract: Methods for producing an isoprenoid are provided. A plurality of bacterial or fungal host cells is obtained. These cells comprise a heterologous nucleic acid encoding one or more enzymes of a mevalonate pathway for making isopentenyl pyrophosphate. Expression of the one or more enzymes is under control one or more heterologous transcriptional regulator. The mevalonate pathway comprises (i) an enzyme that condenses acetoacetyl-CoA with acetyl-CoA to form HMG-CoA, (ii) an enzyme that converts HMG-CoA to mevalonate, (iii) an enzyme that phosphorylates mevalonate to mevalonate 5-phosphate, (iv) an enzyme that converts mevalonate 5-phosphate to mevalonate 5-pyrophosphate, and (v) an enzyme that converts mevalonate 5-pyrophosphate to isopentenyl pyrophosphate. The host cells are cultured in a medium under conditions that are suboptimal as compared to conditions for the maximum growth rate. Temperature is maintained at a level below that which would provide for a maximum specific growth rate for the host cells.
    Type: Grant
    Filed: October 23, 2015
    Date of Patent: October 23, 2018
    Assignee: Amyris, Inc.
    Inventors: Neil Stephen Renninger, Jack Newman, Keith Kinkead Reiling, Rika Regentin, Christopher John Paddon
  • Patent number: 9884803
    Abstract: A method of forming homoallylic compounds 2 from cyclopropylvinyl precursors 1 in the presence of a Bronsted acid HQ
    Type: Grant
    Filed: October 24, 2014
    Date of Patent: February 6, 2018
    Assignees: Givaudan SA, Amyris, Inc.
    Inventor: Fridtjof Schroeder
  • Publication number: 20170283342
    Abstract: A process of converting a carbon-carbon multiple bond to a cyclopropane ring, comprising the addition of a N-alkyl-N-nitroso compound to a mixture of alkene precursor, aqueous base and Pd(II)-catalyst, with the N-alkyl-N-nitroso compound obtained directly from an alkyl amine derivative, NaNO2 and an acid via phase separation of the N-alkyl-N-nitroso compound from the aqueous phase.
    Type: Application
    Filed: June 22, 2017
    Publication date: October 5, 2017
    Applicants: Givaudan, S.A., Amyris Inc.
    Inventors: Fridtjof SCHRÖDER, Fabian RUETHI